Platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine; PAF) acetylhydrolase (PAF-AH) activity has been identified in bovine colostrum and high levels of this activity are found in early colostrum (within 24 h after parturition). In this study, PAF-AH in early colostrum was purified by ammonium sulfate precipitation, and sequential use of butyl-Toyopearl 650M, DEAE-Sepharose, heparin-Sepharose, hydroxyapatite, chelating-Sepharose and Mono Q HPLC column chromatography. This enzyme is a monomeric polypeptide with a molecular weight of approximately 45 kDa on 12.5% SDS-PAGE. The V max and K m for PAF-AH were 87.6 m mM and 7.96 nmol/min/mg respectively. This enzyme was inhibited by phenylmethylsulfonyl fluoride, iodoacetamide and p-bromophenacylbromide, suggesting that both serine and histidine residues are required for enzyme activity. It was not inactivated by NaF or dithiothreitol. The purified enzyme did not degrade phospholipids with a long chain fatty acyl group at the sn-2 position. Accordingly, this enzyme is distinct from phospholipase A 2 . In addition, PAF-AH selectively hydrolyzed oxidatively modified phosphatidylcholine. Furthermore, this enzyme was shown by Western blot analysis using antibody to human plasma PAF-AH to be plasma type PAF-AH. These results clearly demonstrate that 45 kDa plasma type PAF-AH activity exists in bovine colostrum.
Platelet activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a polar phospholipid autacoid that is synthesized in response to stimulation of various types of cells. PAF activates platelets, various cells associated with the inflammatory response and endothelial cells at concentrations as low as 10 Ϫ10 M. It has been shown to increase hypotension, vascular permeability and platelet activation, and cause smooth muscle contraction and edema. 2, 3) PAF has been identified in human plasma 4, 5) and in amniotic fluid, 6, 7) suggesting that it has physiological and/or pathological functions. Its inactivation is catalyzed by a specific acetylhydrolase, which removes the acetyl group on the glycerol backbone, producing the biologically inactive lyso-PAF. This enzyme has been widely distributed in mammalian blood, blood cells and tissues. [8] [9] [10] It has been reported that PAF-acetylhydrolase (AH) can be divided into intracellular (cytosol) and extracellular (plasma) forms. 11, 12) The cytosolic enzyme may help regulate PAF production (e.g. in differentiated macrophages), whereas the plasma form is believed to regulate baseline circulating PAF levels and may be critical in resolving inflammation. 13) PAF-AH from human plasma has been purified and well characterized. 14) This enzyme has an apparent molecular mass of 43 kDa, does not require calcium ions, and is mainly associated with lipoproteins in plasma. Karasawa et al. purified a single polypeptide with a molecular weight of 63 kDa from peritoneal fluid during endotoxin shock induced by Escherichia coli and suggested that this enzyme might be the plasma type. 15) Intracellular acetylhydrolase is a heterotrimeric complex composed of three subunits of 45, 30, and 29 kDa.
16) The 45 kDa subunit, which is not essential for the catalytic activity, exhibits striking homology (99%) with a protein encoded by the causal gene (LIS-1) for Miller-Diecker lissencephaly, a human brain malformation manifested by a smooth cerebral surface and abnormal neural migration.
17) PAF-AH activity has been found in human milk and this enzyme was secreted from macrophages and stable at acidic conditions. 18) We have previously described PAF-AH activity associated with the 45 kDa plasma type in cerebrospinal fluid samples taken from children with a variety of neurological conditions. 19, 20) Recently, we cloned cDNA for PAF-AH by reverse transcription (RT)-PCR from total RNA isolated from the bovine mammary gland. The complete amino acid sequence from the cDNA contained 444 amino acids and was identical to that of PAF-AH isolated from a bovine spleen cDNA library except for two amino acid residue mismatches (Thr-247 to Met and Ile-431 to Thr). 21) Our characterization of PAF-AH in bovine colostrum was however not comprehensive at the protein level.
In the present study, we describe the purification and characterization of 45 kDa plasma type PAF-AH from bovine colostrum.
MATERIALS AND METHODS

Preparation of Enzyme Sources
Bovine colostrums were obtained from stock farm of Yeungnam University. Cells and debris were removed from amniotic fluid by centrifugation condition immediately at 4°C, and then stored at
]acetyl-PAF) were purchased from NEN (Boston, MA, U.S.A.). Butyl-Toyopearl 650M (Toyo Soda Mfg. Co.) DEAE-Sepharose CL-6B, chelatingSepharose, and Mono Q HR5/5 were purchased from Pharmacia Fine Chemicals (Piscataway, NJ, U.S.A.) and Hydroxyapatite was from Biochemical Industry Co., Ltd. (Japan). Bovine serum albumin, phenylmethylsulfonylfluoride, iodoacetamide, dithiothreitol, CHAPS, chymotrypsin were purchased from Sigma Chem. Co. (U.S.A.).
Preparation of Labeled Substrates 1-Acyl-2-[1-14 C]-linoleoyl-sn-glycero-3-phosphocholine and 1-acyl-2-[1-
14 C]-linoleoyl-sn-glycero-3-phosphoethanolamine were synthe-sized as described previously. 22) Preparation of Oxidized Phosphatidylcholine Oxidized phospholipid was prepared as described previously. 23) Briefly, phosphatidylcholine (4 mmol) in 1 ml of 90% acetate was mixed with 2 ml of an oxidation solution (24 mM KMnO 4 , 20 mM NaIO 4 ), and then the mixture was stirred for 2 h at room temperature. The oxidized phosphatidylcholine was separated with a silica gel plate, and then developed with CHCl 3 /CH 3 OH/H 2 O (65/35/10, v/v/v) and the band corresponding oxidized phosphatidylcholine was scrapped off and extracted with chloroform.
Assaying of PAF-AH Activity The standard incubation system for the assaying of PAF-AH comprised 50 mM Tris-HCl (pH 7.4), 5 mM EDTA, 20 nmol [
3 H]acetyl-PAF (3000 cpm/nmol) and 40 ml samples in a total volume of 250 ml. After 30 min at 37°C the reaction was stopped by adding 2.5 ml of chloroform/methanol (4 : 1) and 250 ml of water. Aliquots (600 ml) of the upper phase were used for radioactivity measurement to determine the amount of acetate liberated.
Protein Determination Protein determination was measured with a Pierce protein assay kit according to the manufacturer's instruction (Rockford, IL, U.S.A.). Bovine serum albumin (BSA) served as the protein standard.
Purification Procedure After centrifugation of parturition bovine colostrums (500 ml) at 160ϫg, the supernatants was brought to 40% saturation by adding solid ammonium sulfate, stirred for 30 min, and then centrifuged at 10000ϫg for 30 min. The precipitate was dissolved in 20 mM Tris-HCl (pH 7.4) buffer and this was used as enzyme sources and then dialyzed against the same buffer at 4°C for 24 h. All steps were carried out at 4°C and all buffers contained 0.1% CHAPS, 1 mM EDTA, 5 mM 2-mercaptoethanol (2-ME) and 10% glycerol.
Step 1. Butyl-Toyopearl 650M column chromatography: The dialyzate was loaded on to a column of butyl-Toyopearl 650M column (2.5ϫ10 cm), which had been equilibrated with 30% ammonium sulfate solution. The column was washed with same buffer. The enzyme activity was eluted from the column with in 20 mM Tris-HCl (pH 7.4) (Fig. 1A) . The active fractions were pooled (120 ml) and then dialyzed against the same buffer for 20 h.
Step 2. DEAE-Sepharose CL-6B column chromatography: The dialyzed sample was applied to an anionic exchange column DEAE-Sepharose CL-6B column (2.5ϫ 10 cm) previously equilibrated with 20 mM Tris-HCl (pH 7.4). The column was washed with the same buffer, and then the protein was eluted with a linear gradient of NaCl (0-1 M) in 20 mM Tris-HCl (pH 7.4) buffer. The enzyme activity was eluted from the column with about 0.4 M NaCl (Fig.  1B) . The active fractions were pooled and then dialyzed against the same buffer for 20 h.
Step 3. Heparin-Sepharose CL-6B column chromatography: The dialyzed sample was applied to a column of heparin-Sepharose (2.5ϫ10 cm), which had been equilibrated with 20 mM Tris-HCl (pH 7.4). The column was washed with the same buffer, and then the protein was eluted with 1 M NaCl in 20 mM Tris-HCl (pH 7.4) (Fig. 1C) . The active fractions were pooled and then dialyzed against 20 mM KH 2 PO 4 (pH 6.8) buffer for 20 h.
Step 4. Hydroxyapatite column chromatography: The active fractions from heparin-Sepharose CL-6B column (2.5ϫ4 cm) were applied to hydroxyapatite column previously equilibrated with 20 mM KH 2 PO 4 (pH 6.8) buffer. The column was washed with the same buffer, and then the protein was eluted with 800 mM of KH 2 PO 4 (pH 6.8) (Fig. 1D) . -chelating Sepharose chromatography; (F) Mono Q HPLC chromatography. All steps were carried out at 4°C and all buffers contained 0.1% CHAPS, 1 mM EDTA, 5 mM 2-mercaptoethanol (2-ME) and 10% glycerol. Protein (-) was measured as the absorbance at 280 nm, and the enzyme activity (-) was measured as described under Materials and Methods.
The active fractions were pooled and then dialyzed against 0.5 M NaCl, 20 mM Tris-HCl (pH 8.5) buffer for 20 h.
Step 5. Cu 2ϩ -chelating Sepharose column chromatography: The active fractions from hydroxyapatite column (24 ml) were applied to a column containing chelatingSepharose (2.5ϫ2 cm). The gel was immobilized with Cu 2ϩ by the addition of 1.5 ml of CuSO 4 (5 mg/ml), and subsequently equilibrated with 0.5 M NaCl, 20 mM Tris-HCl (pH 8.5). The column was washed with the same buffer, and then the enzyme activity was desorbed by reducing the pH from 8.5 to 5 with 20 mM containing sodium acetate buffer (pH 5.0) containing 0.5 M NaCl (Fig. 1E) . The active fractions were pooled and then dialyzed against 20 mM Tris-HCl (pH 7.4) buffer for 20 h.
Step 6. Mono Q HPLC column chromatography: The active fractions from Cu 2ϩ -chelating Sepharose column were concentrated using Centricon-TM (Amicon, U.S.A.). The concentrated samples were loaded onto Mono Q HR 5/5 column equilibrated with the same buffer and the protein was eluted in with linear gradient of NaCl (0-1 M) in 20 mM Tris-HCl buffer (Fig. 1F) . The chromatography was performed at the flow rate of 0.5 ml/min and 0.5 ml fractions were collected.
SDS-PAGE/Immunoblot Analysis
The active fractions (Fr. 22-27, 3 ml) from the Mono Q HPLC column chromatography were concentrated and were separated by 12.5% reducing sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred in 20% methanol, 25 mM Tris, and 192 mM glycine to a nitrocellulose membrane (Schleicher and Schull, Dassel, Germany). The nitrocellulose membrane was then blocked by incubation in TTBS (25 mM Tris-HCl, 150 mM NaCl, and 0.2% Tween 20) containing 5% nonfat milk. Subsequently, the membrane was incubated with anti-human plasma antiserum (Cayman Chemicals, Ann Arbor, MI, U.S.A.) for 4 h, washed, and finally incubated for 1 h with a secondary antibody conjugated to horseradish peroxidase. The protein bands were visualized using an enhanced chemiluminesence (ECL) system (GE Healthcare Buckinghamshire, U.K.).
RESULTS
Purification of PAF-AH
We found PAF-AH activity in bovine colostrum. The greatest PAF-AH activity was detected on the day of parturition (day 0), after which its activity dramatically decreased and by day 5, the enzyme activity was less than 7% of the level at parturition (data not shown). Therefore, in order to purify PAF-AH, we used parturition day colostrum as the enzyme source. Bovine colostrum was brought to 40% saturated with solid ammonium sulfate. After centrifugation at 10000 g for 20 min, the precipitates were dissolved in 20 mM Tris-HCl (pH 7.4). This fraction contained approximately 100% of the original activity. This sample (120 ml) was used as the starting enzyme solution, and sequential column chromatographies were performed using butyl-Toyopearl, DEAE-Sepharose, heparin-Sepharose, hydroxyapatite, chealting Sepharose, and Mono Q columns. When the dialysates of ammonium sulfate were load onto the butyl-Toyoperal column, the active fractions were eluted from the column with 0% ammonium sulfate. After dialysis of the active fractions, the dialysates were applied to a DEAE-Sepharose CL-6B column, and the active fractions were eluted from the column with 0.4 M NaCl (Fig. 1B) . When the active fractions (75 ml) from the DEAE-Sepharose column were applied to a heparin-Sepharose column, enzyme activity was eluted from the column with 1 M NaCl (Fig. 1C) . Next, the dialysed active fractions (24 ml) were loaded on to a hydroxyapatite column and enzyme activity was eluted from the column with 0.8 M KH 2 PO 4 (Fig. 1D) . The active fractions (24 ml) from the hydroxyapatite column were dialyzed against 0.5 M NaCl, 20 mM Tris-HCl (pH 8.5) and were applied to a Cu 2ϩ -chelating Sepharose column (Fig.  1E) . The enzyme activity was eluted through the column at pH 6 to 5. The active fractions (41.4 ml) from Cu 2ϩ -chelating Sepharose column were concentrated (4 ml) with Centricon, and dialysed. The dialysates were loaded onto a Mono Q anion HPLC column. The activity was detected in fractions containing 0.34 M NaCl (Fig. 1F) . Table 1 summarizes the results of a typical purification of PAF-AH. The specific activity of the final preparation was increased about 1200-fold and the recovery was 0.1%. From the SDS-PAGE pattern of the preparation at the final step, the apparent molecular weight of this enzyme was consistent with that determined by Western blot, and was approximately 45 kDa (Fig. 2) .
Identification PAF-AH Protein by Western Blot Analysis Purified enzyme was separated by 12.5% reducing sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, Fig. 2A ) and transferred to a nitrocellulose membrane. The immunoblot was then probed with antihuman plasma PAF-AH antibody (1 : 500). Figures 2B and C show that purified PAF-AH was bound to human plasma antiserum. These results suggest that plasma type PAF-AH activity exists in bovine colostrum.
Kinetic Parameters The dependence of the activity of purified PAF-AH on PAF concentration over the range of 1-300 mM is shown in Fig. 3A PAF-AH's reaction with PAF were calculated from the Lineweaver-Burk plot as shown in Fig. 3B . The K m was 87.6 mM and the V max was 7.96 nmol/min/mg. Substrate Specificity As shown in Fig. 4 , the purified enzyme had little or no hydrolyzing activity against phosphatidylcholine or phosphatidylethanolamine with two long acyl chains at the sn-2 position of the glycerol backbone. In contrast, this enzyme selectively hydrolyzed artificially oxidized phophatidylcholine. This result clearly demonstrates that the PAF-AH is distinct from phospholipase A 2 (PLA 2 ) which utilizes long chain diacyl phospholipids as its substrate.
Effect of Various Chemical Reagents
Various compounds were tested for their effect on the activity of the partially purified enzyme (Table 2) . Neither Ca 2ϩ , a cofactor of PLA 2 , nor EDTA, a chelating agent, had any effect upon the enzyme activity. Eight millimolar p-bromophenacylbromide (p-BPB), which has been shown to block various PLA 2 activities by modification of the histidine residue(s) at their active sites, inhibited the activity of the enzyme by about 95%. Eight millimolar phenylmethylsulfonylfluoride (PMSF), which has been shown to block activity by derivatizing the serine residue(s) at their active sites, inhibited the activity of the enzyme by about 98%. In contrast, NaF, a phosphatase inhibitor, and dithiothreitol, which hydrolyzes disulfide bonds so changing protein conformation, did not affect enzyme activity. Iodoacetamide, an inhibitor of enzymes that needs free sulfhydryl groups for their activity, inhibited PAF- Purified PAF-AH (5 mg) and human plasma (20 ml) were separated by 12.5% reducing sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and the gel was stained with CBB staining. The immunoblot was then probed with anti-human plasma PAF-AH antibody (1 : 500) at a dilution of 1 : 500. SDS-PAGE and Western blot analysis were carried out as described under Materials and Methods. Molecular weight standards: bovine serum albumin (66 K), ovalbumin (45 K), carbonic anhydrase (29 K) and cytochrome c (12.4 K). Fig. 3 . Effect of Substrate Concentration on the Activity of the Purified PAF-AH PAF-AH activity was assayed with various concentrations from 1 to 100 mM of radioactive PAF. An untransformed plot (A) and Lineweaver-Burk (double-reciprocal) plot (B) are shown. Vertical bars, standard deviation.
Fig. 4. Hydrolyzing Activity of PAF Acetylhydrolase towards Various Phospholipids
The standard incubation system for the assaying of PAF-AH against oxidized PC comprised 50 mM Tris-HCl (pH 7.4), 5 mM EDTA, 20 nmol oxidizes PC (3000 cpm/nmol) and 10 ml purified enzyme in a total volume of 250 ml. After 30 min at 37°C the reaction was stopped by adding 2.5 ml of chloroform/methanol (4 : 1) and 250 ml of water. Aliquots (600 ml) of the upper phase were used for radioactivity measurement to determine the amount of radioactivity. The enzyme had little or no activity against phosphatidylcholine, or phosphatidylethanolamine with two long acyl chains. In contrast, this enzyme selectively hydrolyzed oxidized phosphatidylcholine. Each compound was incubated with PAF-AH for 15 min at 22°C and then the enzyme reaction was started by adding the substrate. a) Each compound was dissolved in ethanol so that the final concentration of ethanol was 5% (v/v). b) This value represents the average of duplicated determinations.
AH activity. These results suggest that the active site of PAF-AH in bovine colostrum might be at the serine and histidine residues.
DISCUSSION
We reported recently the cloning of cDNA for PAF-AH by RT-PCR from total RNA isolated from bovine mammary glands. 21) However, our characterization of bovine colostrum PAF-AH at the protein level was not comprehensive. As there is limited knowledge about this enzyme in bovine colostrum, we tried to purify PAF-AH from bovine milk by sequential use of DEAE-Sepharose CL-6B, heparin-Sepharose, hydroxyapatite, chelating-Sepharose and Mono Q HPLC column chromatographies. After the final step, PAF-AH was purified about 1200 fold. PAF-AH(s) have been purified from various sources. 7, 10, 15, 16, 24, 27) Stafforini et al. purified human plasma PAF-AH and determined its molecular weight to be 43 kDa. 10) We identified a monomeric polypeptide with a molecular weight of approximately 45 kDa on 12.5% SDS-PAGE, which corresponded well with other known plasma type PAF-AH(s). 7, 10, 20) The purified PAF-AH from bovine colostrum was inhibited by PMSF, p-BPB and idodoacetamide (Table 2) . PAF-AH activity in human amniotic fluid and in cerebrospinal fluid of children with meningitis were inhibited by both PMSF and p-BPB, but were not inhibited by iodoacetamide. 7, 20) Purified PAF-AH activity in guinea pig peritoneal fluid after Escherichia coli LPS administration was not inhibited by p-BPB, NaF and trypsin, like human plasma PAF-AH. 15) Purified PAF-AH from bovine colostrum was Ca 2ϩ independent and did not hydrolyze the ester bond of phospholipids with a long chain fatty acyl group at the sn-2 position. This purified enzyme is distinguishable from PLA 2 , which requires a divalent cation, such as Ca 2ϩ , and shows a broad range of activity against fatty acids esterified at the sn-2 position. Moreover, PLA 2 activity was not detected at any of the purification steps (data not shown). It has been reported that PAF-AH can be grouped into two types, plasma and intracellular. 11, 12) Blank et al. reported that the plasma type had a higher molecular weight than the intracellular type and was resistant to protease, whereas the intracellular enzyme was not. 25) PAF-AH purified from bovine brain cytosol, which includes the intracellular type, was inhibited by p-BPB and diisopropylphenylphosphate (DFP), but was not inhibited by iodoacetamide and a reducing agent was essential for optimal activity. 16) Oxidative degradation of phospholipids results in the formation of biologically active products, 27) and these phospholipids are involved in some pathological states including atherogenesis. 28) Patel et al. reported that exposing of vascular endothelial cells to tert-butyl-hydroxyperoxide led to the fragmentation of cellular phosphatidylcholine to yield PAF-like phospholipids with potent biological activity toward neutrophils.
29) It should be mentioned here that similar to several other PAF-AH(s), 7, 15) bovine colostrum PAF-AH can hydrolyze oxidatively modified phospholipids. As shown in Fig. 4 , the purified enzyme had little or no activity against phosphatidylcholine or phosphatidylethanolamine with two long acyl chains. In contrast, this enzyme selectively hydrolyzed artificially oxidized phophatidylcholine. Thus PAF-AH in colostrum might be involved in excluding PAF-like oxidized phospholipids. However, the biochemical properties of this enzyme in colostrum that scavenge (per)oxidized phospholipids remain totally unknown.
Furukawa et al. reported the presence of PAF-AH activity in the milk of various species.
18) However, they could not detect PAF-AH activity in cow milk. High PAF-AH activity was found in the colostrum obtained from the first day, and then enzyme activity dramatically decreased (data not shown). The biochemical properties such as heat stability and pH profile (data not shown) were consistent with that of human milk enzymes. 18) It is well known that PAF is one of the most proinflammatory agents thus far described and has been implicated in the development of certain inflammatory diseases of the small and large intestine. Caplan et al. have suggested a role for PAF along with endotoxin and tumor necrosis factor-a (TNF-a) in the development of necrotizing enterocolitis (NEC) of new born. 29) The potential importance of PAF-AH in NEC is supported by the finding that human milk or recombinant PAF-AH can prevent NEC. [30] [31] [32] PAF-AH activity is present in bovine colostrum and this enzyme also may be secreted by bovine macrophages. Therefore, PAF-AH in bovine colostrum may be useful to prevent the development of NEC. The function of PAF-AH in bovine colostrum remains unknown. To understand the physiological role of PAF-AH in colostrum, further studies must be performed.
